3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
26
Pain, Postoperative
17
Neoplasms
13
Lung Neoplasms
12
Brain Neoplasms
12
Depression
7
Carcinoma, Hepatocellular
7
Pain
6
Colonic Neoplasms
6
Thyroid Neoplasms
5
Stomach Neoplasms
5
Prostatic Neoplasms
5
Leiomyoma
5
Head and Neck Neoplasms
5
Agnosia
5
Ovarian Neoplasms
4
Multiple Myeloma
4
Delirium
4
Colorectal Neoplasms
4
Anxiety Disorders
4
Supratentorial Neoplasms
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Myofibroma
3
Lymphoma
3
Hemorrhage
3
Fatigue
3
Emergence Delirium
3
Chronic Pain
3
Carcinoma, Non-Small-Cell Lung
3
Interventions
Escitalopram
3
Psilocybin
2
Interpersonal Psychotherapy
2
Infliximab
2
abacavir
1
Vortioxetine
1
Venlafaxine Hydrochloride
1
Transcranial Magnetic Stimulation
1
Sugars
1
Saline Solution
1
Mirtazapine
1
Magnetic Resonance Spectroscopy
1
Ketamine
1
Fatty Acids, Omega-3
1
Diagnostic Imaging
1
Desvenlafaxine Succinate
1
Cognitive Behavioral Therapy
1
Citalopram
1
Bupropion
1
Antidepressive Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Depressive Disorder, Major
×
Saline Solution
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts